James C. Yao

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-1875-3962

发表论文 596 篇 · 总被引 39628 次 · h-index 81

代表论文

• SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade (2025 · Nature · 被引 108)
• Epidemiology of Neuroendocrine Neoplasms in the US (2025 · JAMA Network Open · 被引 81)
• Changes in the 6th edition of the World Health Organization classification of tumours of the digestive system (2026 · Histopathology · 被引 7)
• A phase II study of lenvatinib plus everolimus in advanced extra-pancreatic neuroendocrine tumors (epNETs): Updated results and real-world comparison. (2025 · Journal of Clinical Oncology · 被引 2)
• Phase I-II trial of perioperative chemotherapy plus atezolizumab and tiragolumab in localized esophageal and gastroesophageal junction adenocarcinoma. (2026 · Journal of Clinical Oncology · 被引 1)
• Supplementary Figure S2 from Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal (2026)